Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Mitochondrial approaches for neuroprotection.
Sanofi withdraws Campath in US and EU
Normal-appearing white matter in multiple sclerosis is in a subtle balance between inflammation and neuroprotection.
Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH.
The INCAT disability score: A critical analysis of its measurement properties.
Axonal and oligodendrocyte-localized IgM and IgG deposits in MS lesions.
Physiopathological Roles of p2x Receptors in the Central Nervous System.
Role of the Blood-Brain Barrier in Multiple Sclerosis.
Increased CD8+ T Cell Response to Epstein-Barr Virus Lytic Antigens in the Active Phase of Multiple Sclerosis.
The Vitamin D to Ameliorate Multiple Sclerosis (VIDAMS) trial: study design for a multicenter, randomized, double-blind controlled trial of vitamin D in multiple sclerosis.
Stress Management and Multiple Sclerosis: A Randomized Controlled Trial.
Peripheral and Central Nervous System Drugs Advisory Committee Meeting: Alemtuzumab (BLA 103948\5139) Background Package
Recombinant T cell receptor ligands: immunomodulatory, neuroprotective and neuroregenerative effects suggest application as therapy for multiple sclerosis.
Therapeutic effects of novel sphingosine-1-phosphate receptor agonist W-061 in murine DSS colitis.
A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis.
Teva Announces U.S. Supreme Court Will Hear Its Appeal on COPAXONE(R) Patent
The Gulf War era multiple sclerosis cohort: age and incidence rates by race, sex and service.
Interferon beta 1b following natalizumab discontinuation: one year, randomized, prospective, pilot trial.
Phase 2 BOLD extension study efficacy results for siponimod (BAF312) in patients with relapsing-remitting multiple sclerosis.
Glatiramer acetate and interferon-beta throughout gestation and postpartum in women with multiple sclerosis.
Effects of rituximab on lymphocytes in multiple sclerosis and neuromyelitis optica.
Pediatric multiple sclerosis.
Balance impairment in people with multiple sclerosis: Preliminary evidence for the Balance Evaluation Systems Test.
Rescue Therapy Using Rituximab for Multiple Sclerosis.
Comparing the biological impact of glatiramer acetate with the biological impact of a generic.

Pages